Inadequate response to imatinib treatment in chronic myeloid leukemia due to a drug interaction with phenytoin
2019
Imatinib mesylate and the newer BCR-ABL tyrosine kinase inhibitors are the standard therapy for chronic myeloid leukemia. Although these are remarkably effective drugs, some mechanisms of resistanc...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
29
References
6
Citations
NaN
KQI